ABL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Abbott Laboratories

Watchlist Manager

Watchlist

Price: 96.14 EUR -2.28% Market Closed

Market Cap: €170B

A	Abbott Laboratories XHAM:ABL	US
A	Anika Therapeutics Inc F:AKP	US
	Thungela Resources Ltd F:6UP	ZA
E	Eni SpA DUS:ENI	IT
I	Intesa Sanpaolo SpA DUS:IES	IT

Profitability Summary

Abbott Laboratories's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

57%

Strong 3Y Average Gross Margin

56%

Gross Margin is Increasing

55% > 57%

Healthy Operating Margin

17%

Sustainable 3Y Average Operating Margin

17%

Operating Margin is Increasing

16% > 17%

Healthy Net Margin

12%

Sustainable 3Y Average Net Margin

20%

Declining Net Margin

13% > 12%

Exceptional Free Cash Flow Margin

17%

Strong 3Y Average Free Cash Flow Margin

15%

Free Cash Flow Margin is Increasing

14% > 17%

Positive ROE

11%

Positive 3Y Average ROE

Positive 3Y Average ROIC

13%

Declining ROIC

9% > 7%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.